Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

417 trials with published results (11%)

Research Maturity

2017 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.7%

304 terminated out of 3930 trials

Success Rate

86.9%

+0.4% vs benchmark

Late-Stage Pipeline

6%

239 trials in Phase 3/4

Results Transparency

21%

417 of 2017 completed with results

Key Signals

417 with results87% success304 terminated

Data Visualizations

Phase Distribution

2,721Total
Not Applicable (1480)
Early P 1 (32)
P 1 (624)
P 2 (346)
P 3 (173)
P 4 (66)

Trial Status

Completed2,017
Recruiting624
Unknown468
Terminated304
Active Not Recruiting182
Not Yet Recruiting167

Trial Success Rate

86.9%

Benchmark: 86.5%

Based on 2017 completed trials

Clinical Trials (3930)

Showing 20 of 20 trials
NCT06051695Phase 1Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT02108028Completed

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

NCT07454499Not ApplicableRecruitingPrimary

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

NCT05456100Not ApplicableActive Not RecruitingPrimary

Chinese American Cancer Survivors Writing Study

NCT07019259Not ApplicableRecruitingPrimary

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

NCT06931561Not ApplicableRecruitingPrimary

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

NCT07303816Phase 4Recruiting

Statins to Prevent Cancer Associated Blood Clots

NCT05030701Completed

Toxicity of Treatments for Non-tuberculous Mycobacterial Infections in Cancer Patients or Not

NCT05862285Phase 3RecruitingPrimary

A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

NCT04537195Not ApplicableActive Not Recruiting

Effects of a Lay-led Anxiety and Depression Self-management Program for Cancer Patients

NCT06475807Not ApplicableRecruitingPrimary

Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors

NCT06184256Not ApplicableCompleted

BfedBwell Optimization Pilot

NCT07643558Not ApplicableRecruiting

Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance Training on Skeletal Muscle Status in Gynaecological, Gastrointestinal and Urological Cancer Patients

NCT06505122Not ApplicableTerminatedPrimary

Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers

NCT01143480Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT05754840Phase 1Recruiting

CANnabinoids in Pediatric ONCology

NCT07643389Not ApplicableCompletedPrimary

EXCEL-Punjabi: A Culturally Tailored Exercise Oncology Pilot Feasibility Intervention

NCT07218003Phase 1Enrolling By Invitation

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

NCT05588141Phase 1Recruiting

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT04609072RecruitingPrimary

Connect for Cancer Prevention Study (Connect)

Scroll to load more

Research Network

Activity Timeline